Page 166 - CW E-Magazine (19-8-2025)
P. 166

Special Report


       Metal-free catalysis is transforming the future

       of sustainable pharmaceutical innovation


            he pharmaceutical industry today                               CHINMOY HAZRA
            faces a pressing dual challenge:
       Taccelerating  the  discovery  of                                   Associate Professor
                                                                           Department of Chemistry
       innovative  therapies  while  dramatically                          Indian Institute of Technology, Delhi
       reducing  its  environmental  footprint.
       Estimates indicate that global pharma-                             green  credentials.  Unlike  Lewis  acid
       ceutical emissions account for approxi-                            or  metal-based  systems,  Brønsted
       mately 52-million tonnes of CO₂ each                               acid  catalysis  employs  proton  donors,
       year,  surpassing  even  the  automotive                           organic  acids  such  as  sulphonic  acids
       sector  in  emissions  intensity. The  call                        or  phosphoric  acids,  to  activate  sub-
       for  greener,  more  sustainable  chemis-                          strates  via  hydrogen-bonding  or
       try has become imperative. Alongside                               protonation  in  chemical  transformation.
       rising research and development costs,                             These  acids  are  typically  less  toxic,
       tightening  regulations  are  compelling                           more aff ordable, and readily available,
       companies  to  reevaluate  long-esta-                              making  them  ideal  for  scale-up  in
       blished methods of chemical synthesis.                             industrial settings.
       In this context, metal-free catalysis has  metals  have  played  an  indispensable
       emerged  as  a  promising  strategy  for  role  in  driving  reactivity  and  selecti-  Mechanistically, Brønsted acids can
       designing  safer,  cleaner,  and  more  vity across a wide range of transforma-  facilitate  a  broad  range  of  reactions,
       scalable routes to complex drug mole-  tions. Yet  they  also  introduce  notable  including  C-C  (carbon–carbon)  bond
       cules.                            drawbacks.  Many  are  scarce,  expen-  formation,  cyclizations,  rearrange-
                                         sive, and toxic in even trace quantities.  ments,  and  condensations,  many  of
          Recent  market  studies  refl ect  this  To  comply  with  international  health  which are essential in the development
       momentum.  The  global  green  chemi-  regulations,  companies  must  invest  of  active  pharmaceutical  ingredients
       cals  market  is  projected  to  reach  signifi cant  resources  to  remove  resi-  (APIs). This mechanism not only off ers
       $167.9-bn by  2030,  with  a  CAGR  of  dual metals from drug products, adding  effi  ciency  but  also  opens  pathways  to
       10.8%.  This  expansion  is  driven  by  further  environmental  and  economic  molecular  complexity  without  com-
       growing  regulatory  scrutiny,  evolving  burden.                  promising  environmental  standards.
       investor  expectations,  and  recogni-                             In many cases, they can be employed
       tion  across  the  sector  that  sustainable   Metal-free  catalysis  provides  a  under  milder  reaction  conditions  and
       processes  can  improve  operational  compelling  alternative.  Rather  than  are  compatible  with  aqueous  media,
       resilience  and  long-term  competitive-  relying  on  precious  or  critical  metals,  further  reducing  the  environmental
       ness.                             these  systems  employ  organic  acids  and  energy  footprint  of  the  process.
                                         or  small-molecule  organocatalysts  to  Additionally,  their  homogeneous  nature
          Among  the  various  approaches  mediate reactions. The result is a mea-  allows  for  better  control  and  reproduci-
       gaining  ground,  Brønsted  acid  cata-  surable reduction in hazardous waste, a  bility during  scale-up,  which  is  critical
       lysis  stands  out  for  its  capacity  to  lower risk of contamination, and fewer  in pharmaceutical manufacturing.
       balance  environmental  benefi ts  with  energy-intensive purifi cation steps. As
       robust  performance  in  pharmaceutical  environmental  regulations  continue  to   One  of  the  key  advantages  of  this
       synthesis.                        evolve,  metal-free  catalysis  is  becom-  approach is the potential for reusability.
                                         ing less of a niche innovation and more  Recent studies have demonstrated that
       Why sustainable catalysis is now   of a viable standard for the industry.  carefully  designed  Brønsted  acid  sys-
       a necessity                                                        tems  can  be  recycled  across  multiple
          For  decades,  pharmaceutical  pro-  Understanding Brønsted acid catalysis  reaction cycles without signifi cant loss
       cesses have depended heavily on transi-  Among  emerging  solutions,  Brøn-  in activity. Strong organic Brønsted acids
       tion metal-based catalysts such as palla-  sted  acid  catalysis  is  gaining  traction  can achieve high catalytic effi  ciency at
       dium,  rhodium,  and  ruthenium. These  due to its simplicity, accessibility, and  low concentrations, producing minimal

       166                                                                    Chemical Weekly  August 19, 2025


                                      Contents    Index to Advertisers    Index to Products Advertised
   161   162   163   164   165   166   167   168   169   170   171